.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Baxter
Moodys
AstraZeneca
Accenture
Harvard Business School
Argus Health
Covington
Healthtrust

Generated: November 24, 2017

DrugPatentWatch Database Preview

DOXYLAMINE SUCCINATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for doxylamine succinate and what is the scope of doxylamine succinate patent protection?

Doxylamine succinate
is the generic ingredient in eight branded drugs marketed by Copley Pharm, Quantum Pharmics, Sanofi Aventis Us, Pfizer, Par Pharm, LNK, Chattem, Perrigo, Actavis Labs Fl Inc, and Duchesnay, and is included in twelve NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for doxylamine succinate. Thirty-one suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for DOXYLAMINE SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lnk
DOXYLAMINE SUCCINATE
doxylamine succinate
TABLET;ORAL040564-001Aug 27, 2004OTCNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL205811-001Aug 19, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Duchesnay
BONJESTA
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL209661-001Nov 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Duchesnay
BONJESTA
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL209661-001Nov 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Sanofi Aventis Us
DECAPRYN
doxylamine succinate
TABLET;ORAL006412-015Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Duchesnay
DICLEGIS
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL021876-001Apr 8, 2013ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Pfizer
UNISOM
doxylamine succinate
CAPSULE;ORAL019440-001Feb 5, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Duchesnay
BONJESTA
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL209661-001Nov 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Perrigo
DOXYLAMINE SUCCINATE
doxylamine succinate
TABLET;ORAL040167-001Sep 18, 1996OTCNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
DOXY-SLEEP-AID
doxylamine succinate
TABLET;ORAL070156-001Jul 2, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Harvard Business School
Daiichi Sankyo
Baxter
Federal Trade Commission
Farmers Insurance
Express Scripts
Merck
Queensland Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot